Open Label, Prospective, Exploratory Study to Investigate the Effect of Inhaled CHF5993 pMDI on Central and Peripheral Airway Dimensions in COPD Patients by Functional Respiratory Imaging
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Beclometasone/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- Acronyms FRI
- Sponsors Chiesi Farmaceutici SpA
- 23 Nov 2017 Planned End Date changed from 30 Jan 2019 to 30 Sep 2018.
- 23 Nov 2017 Planned primary completion date changed from 31 Jul 2018 to 30 Sep 2018.
- 23 Nov 2017 Status changed from not yet recruiting to recruiting.